Analyzing Alpha-Synuclein Mediated Disorders Through Patient Imaging Data

This chapter discusses the influence of alpha-synuclein on neurodegenerative disorders, highlighting imaging data and the significance of clinical context. It details patient selection criteria from a key brain bank study, emphasizing the careful exclusion of conditions to ensure accurate evaluation of Parkinsonian syndromes.